Amended and Restated SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 14th, 2025 • Glycomimetics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 14th, 2025 Company Industry JurisdictionThis Amended and Restated SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of February 14, 2025, by and among Crescent Biopharma, Inc., a Delaware corporation (“Crescent”), GlycoMimetics, Inc., a Delaware corporation (“Parent”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).
Amended and Restated SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 14th, 2025 • Glycomimetics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 14th, 2025 Company Industry JurisdictionThis Amended and Restated SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of February 14, 2025, by and among Crescent Biopharma, Inc., a Delaware corporation (“Crescent”), GlycoMimetics, Inc., a Delaware corporation (“Parent”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).